In An Effort To Study And Regulate CBD, FDA Is Hiring Contractors To Test Thousands Of Cannabidiol Products.
The Food and Drug Administration (FDA) is looking to award a contract to help study CBD as the agency develops regulations for products containing the non-intoxicating cannabinoid. The selected company would then have to work with 1,000-3,000 samples and assess the quantities of CBD and related cannabinoids, as well as potential associated contaminants including the likes of pesticides, toxic elements, industrial chemicals, and more. The results of the studies would then be sent to Congress and used for further studies and developing regulations. The main samples would include CBD-containing packaged and processed foods along with regular options like pills, oils, and gummies. These would be analyzed for CBD, CBDA, THC, THCA, in addition to other cannabinoid content.
The purpose of these studies will be to develop a better understanding of the quantities of CBD and associated cannabinoids and their distribution. The goal will be to collect and analyze a statistically relevant number of samples.
The last day to apply for becoming a FDA’s contractor for CBD research is August 31. The agency has been constantly working to come up with regulations for CBD following the legalization of hemp and its derivatives in the 2018 Farm Bill. The FDA also released guidance about conducting research into cannabis for drug development purposes which was reviewed by the White House.
Read Full Article: https://www.marijuanamoment.net
CBD is one of many powerful cannabinoids found in hemp known for helping to support our body and mind. Here at Healing Dragon CBD we do not intend to make unfounded medical claims about the health benefits of CBD. The FDA has not confirmed that CBD cures, treats, or prevents any diseases or conditions. Before reading this article please take a moment to read our full disclosure statement.